SCHEMBL6311782

SCHEMBL6311782

CCc1nc(-c2c(C)c(C#N)c3nc4ccccn4c3c2Cl)cs1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.34
NR1I2 O75469 1/20 0.34
NR1I3 Q14994 1/20 0.34
MAPT P10636 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
LMNA P02545 3/20 0.33
NPSR1 Q6W5P4 3/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
MDM2 Q00987 1/20 0.33
HSD17B10 Q99714 4/20 0.32
MAPK1 P28482 4/20 0.32
ALDH1A1 P00352 4/20 0.32
HPGD P15428 3/20 0.32
HTT P42858 3/20 0.32
PIK3CD O00329 4/20 0.30
KMT2A Q03164 2/20 0.30
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6310683 0.88 KDM4E (0.36) KDM4EMAPTSMN1; SMN2LMNANPSR1
SCHEMBL6311027 0.85 SREBF2 (0.38) KDM4EMAPTSMN1; SMN2NPSR1RAB9A
SCHEMBL6311042 0.81 KDM4E (0.45) KDM4EMAPTSMN1; SMN2NPSR1HSD17B10
SCHEMBL6310328 0.79 NPSR1 (0.44) KDM4EMAPTSMN1; SMN2LMNANPSR1
SCHEMBL6310367 0.79 HTT (0.43) KDM4ESMN1; SMN2LMNARAB9ANPC1
SCHEMBL6319505 0.78 KDM4E (0.34) KDM4ERAB9ANPC1HSD17B10ALDH1A1
SCHEMBL6312786 0.78 KDM4E (0.44) KDM4EMAPTSMN1; SMN2LMNANPSR1
SCHEMBL6311468 0.75 HPGD (0.45) KDM4EMAPTSMN1; SMN2LMNANPSR1
SCHEMBL6309849 0.74 KDM4E (0.41) KDM4EMAPTNPSR1RAB9ANPC1
SCHEMBL6312086 0.74 MAPT (0.47) KDM4EMAPTSMN1; SMN2LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KDM4E 3360/4885NR1I2 673/4885NR1I3 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.